Honoured to have been elected chair of the @escardio#EAPC_ESC#sports#cardiology& #exercise section for the 2022-24 mandate. Humbled to be the 1st woman elected in this position. Thank you to all the nucleus members who supported my election! Looking forward to working together
RISE @ ESC Congress 2026 Program Director @mrubini shares why this year’s event matters for women in CV medicine, from mentorship & career growth to practical education & global connection.
Early reg ends May 31.
Register now: https://t.co/2EjU2pA6Et
#LetsRISE26#ESCCongress
Even before diabetes develops, dysglycaemia may increase AF risk. ⚠️
A meta-analysis including 26.4 million participants showed that prediabetes was associated with ⬆️15% risk of AF, supporting a dose–response relationship across glucose levels.
🔗https://t.co/KhJ8mp845N
New in #EJPC: Cuffless Blood Pressure Monitoring Devices: Technical Foundations and Clinical Implications: Scientific Statement of the European Society of Cardiology (ESC) Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESC
https://t.co/9sFxL5OtLg
@EJPCEiC@AboyansV@SilCastelletti@PTBuketAkinci@PeroneFrancesco@SMosteoru@TimKambic
Early registration for RISE @ ESC Congress 2026 ends in 1 week (prices increase on 1 June).
Join a full day of leadership development, practical skills, and connection, focused on real-world impact and career growth.
Register: https://t.co/2EjU2pzyOV
#LetsRISE26#ESCCongress
🏃♂️ More than 1 in 3 athletes show elevated cardiac troponin levels after exercise. This meta-analysis highlights that elevations are most common after endurance events lasting 3–6 h and with high-sensitivity cTnT assays.🫀
🔗https://t.co/JvL7v7N9gj
#sportscardiology
At RISE @ ESC Congress 2026, learn to define quality metrics, apply change management, and turn data into clinical improvement.
@SilCastelletti will lead an interactive workshop focused on practical, real-world impact.
Register: https://t.co/ZZeFgg57su
#LetsRISE26#ESCCongress
At RISE @ ESC Congress 2026, learn to define quality metrics, apply change management, and turn data into clinical improvement.
@SilCastelletti will lead an interactive workshop focused on practical, real-world impact.
Register: https://t.co/ZZeFgg57su
#LetsRISE26#ESCCongress
🌍 Climate change is increasingly a cardiovascular health issue. Rising temperatures, air pollution, and extreme weather events are reshaping cardiometabolic risk profiles.
Is healthcare prepared for climate-resilient cardiovascular prevention?
New in #EJPC : https://t.co/KTsE8InLAa
@EJPCEiC@AboyansV@SilCastelletti@PTBuketAkinci@PeroneFrancesco@SMosteoru@TimKambic #cvprev
Remotely derived digital health interventions can effectively encourage self-care among patients with stable CAD.
Read the Editorial published in the #EJPC: "Digital health interventions for cardiac rehabilitation in stable coronary artery disease". 👇
@AboyansV@SilCastelletti
Sitting less isn’t enough — how you move matters. 🚶♀️📊 New systematic review & meta-analysis of 144 RCTs shows that different physical activity trends produce different cardiometabolic benefits.
Transient extreme HR spikes on HT monitors may not simply be artefacts ⌚⚡In endurance athletes, paroxysmal spike patterns were strongly associated with clinically documented arrhythmias, highlighting the potential role of HRMs as surveillance tools.
https://t.co/BSQeQf8x0L
Aerobic exercise plays a vital role in the long-term care of diabetic patients following PCI 📣
Read the interesting new Editorial published in the #EJPC: "Aerobic exercise after PCI in diabetes: a pillar for cardiovascular prevention" by Prof. Roberto F. E. Pedretti et al.
👇👇
This Technology-bAsed Cardiac rehabilitation Therapy (TACT) program significantly improves functional capacity, QoL, heart-health behaviours and anxiety in women with CVDs in a middle-income country
📖 https://t.co/09hnMoqwWQ
@escardio@AboyansV@SilCastelletti
Read new interesting Editorial published in the #EJPC: "Self-selected cardiac rehabilitation trajectories: increasing patient empowerment".
This editorial refers to: by P. Eser et al., https://t.co/qSsMLKBzLN. 📔
Good reading #cvprev community!
@EJPCEiC@AboyansV#cvprev
✅ This study suggests that low-dose colchicine (0.5 mg once daily) may reduce arterial stiffness in high risk patients with type 2 diabetes.
➡️ This reduction occurred despite low baseline levels of CRP
📕 https://t.co/i5wl5KheHt
@escardio@AboyansV@SilCastelletti#cvprev